| 1 |
Bollerslev J, Harris ST, Leder BZ. Medicines and bone loss. J Clin Endocrinol Metab 2013;98:33A-34A.
DOI
|
| 2 |
McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-2219.
DOI
ScienceOn
|
| 3 |
Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-397.
DOI
ScienceOn
|
| 4 |
Yoon J, Kwon SR, Lim MJ, et al. A comparison of three different guidelines for osteoporosis treatment in patients with rheumatoid arthritis in Korea. Korean J Intern Med 2010;25:436-446.
DOI
ScienceOn
|
| 5 |
Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid- induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007;18:1319-1328.
DOI
ScienceOn
|
| 6 |
Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010;62:1515-1526.
DOI
|
| 7 |
Lee JH, Cho SK, Han M, Kim D, Bae SC, Sung YK. Are glucocorticoid-induced osteoporosis recommendations sufficient to determine antiosteoporotic treatment for patients with rheumatoid arthritis? Korean J Intern Med 2014;29:509-515.
DOI
ScienceOn
|
| 8 |
Berry SD, Kiel DP, Donaldson MG, et al. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int 2010;21:53-60.
DOI
ScienceOn
|
| 9 |
Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004;34:195-202.
DOI
ScienceOn
|
| 10 |
Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA 2001;286:2815-2822.
DOI
ScienceOn
|
webmaster
